HTG Molecular Diagnostics Announces Proposed Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Nasdaq ends down as chipmakers fall and bank earnings roll in
- Oil prices settle mixed, focus on US-Russia diesel deal, Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
HTG Molecular Diagnostics (HTGM) Prices $20M Financing, Consisting of $16.6M Public Offering of Common Stock, $3.5M Concurrent Private Placement
September 20, 2019 9:31 AM EDTHTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced the pricing of an underwritten public offering of 25,476,989 shares of its common stock at a price to the public of $0.65 per share. All of the shares are being sold by HTG. The gross proceeds from the public offering are expected to be approximately $16.6... More



